AKT1 and hepatocellular carcinoma: However, the clinical relevance of the PI3K/Akt pathway as an innovative target in HCC and its therapeutic potential remain to be further elucidated, in parallel with our growing knowledge of the role of signaling pathways and their alterations involved in HCC pathogenesis.